1-8 of 8
Lori A. Hazlehurst, Ph.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PYK2 Mediates Microenvironment-Specific Myeloma Survival

Mark Meads, PhD, Bin Fang, PhD, Linda Mathews, Jennifer Gemmer, Liang Nong, M.D., Lori A Hazlehurst, Ph.D, Robert MacLeod, PhD, John Koomen, Ph.D., Kenneth Shain, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4443.
https://doi.org/10.1182/blood.V122.21.4443.4443
Published: 2013
Journal Articles

Bone Marrow Beta-Catenin Expression In Chronic Myelogenous Leukemia Patients Treated With Imatinib

Xiaohui Zhang, MD, Kendra L Sweet, MD, MS, Lynn Moscinski, MD, Lori A Hazlehurst, Ph.D, Javier Pinilla-Ibarz, MD, PhD, Ling Zhang, MD
Journal: Blood
Blood (2013) 122 (21): 2739.
https://doi.org/10.1182/blood.V122.21.2739.2739
Published: 2013
Journal Articles

Personalizing Myeloma Chemotherapy Using Evolutionary Computational Models and Ex Vivo Assays.

Ariosto Siqueira Silva, PhD, Zayar Khin, BSc, Kenneth H Shain, MD, Ph.D, Rachid Baz, MD, Lori A Hazlehurst, Ph.D, Ashley Durand, BSc, Robert Gatenby, MD
Journal: Blood
Blood (2012) 120 (21): 2960.
https://doi.org/10.1182/blood.V120.21.2960.2960
Published: 2012
Journal Articles

Mti-101 Induces Necrotic Cell Death in AML Cells Through Its Binding to Cell Surface Complexes Containing CD44 and ITGA4

Rajesh R Nair, Ph.D., Joel H Tolentino, PhD, Milijana Ugrenovic, BSc, Priyesh R Jain, Ph.D., Mark L McLaughlin, Ph.D., Jeffrey E Lancet, MD, Lori A Hazlehurst, Ph.D
Journal: Blood
Blood (2012) 120 (21): 869.
https://doi.org/10.1182/blood.V120.21.869.869
Published: 2012
Journal Articles

Mti-101 (cyclized HYD1) Binds to CD44 and Induces Necrotic Cell Death in Multiple Myeloma

Anthony W. Gebhard, M.S., Rajesh R Nair, Ph.D., Michael Emmons, Ph.D, Priyesh R Jain, Ph.D., Andreas Becker, Ph.D., John Koomen, Ph.D., Ernst Schonbrunn, Ph.D., Daniel M Sullivan, MD, Mark L McLaughlin, Ph.D., Lori A Hazlehurst, Ph.D
Journal: Blood
Blood (2012) 120 (21): 4022.
https://doi.org/10.1182/blood.V120.21.4022.4022
Published: 2012
Journal Articles

Prognostic Significance of VLA4 and CD44 Expression by Flow Cytometry in Multiple Myeloma (MM)

Wasif Riaz, MBBS, John Pham, Ling Zhang, MD, Lynn Moscinski, MD, Lori A Hazlehurst, Ph.D, Michael Emmons, Ph.D, Daniel M Sullivan, MD, Kenneth H Shain, MD, Ph.D, Conor Lynch, Ph.D, Yue Binglin, Hui-Yi Lin, Ph.D, Rachid Baz, MD
Journal: Blood
Blood (2012) 120 (21): 4975.
https://doi.org/10.1182/blood.V120.21.4975.4975
Published: 2012
Journal Articles

NF-kB as a Regulator of FA/BRCA Gene Expression in Multiple Myeloma.

Vasco A. Oliveira, PhD, Linda Mathews, B.Sc., Danielle Yarde, B.Sc, Xingyu Wang, Ph.D., David Boulware, M.Sc., Lori A. Hazlehurst, Ph.D., Dung-Tsa Chen, Ph.D., Amer Beg, Ph.D., William S. Dalton, M.D., Ph.D.
Journal: Blood
Blood (2007) 110 (11): 3508.
https://doi.org/10.1182/blood.V110.11.3508.3508
Published: 2007
Journal Articles

Bortezomib Enhances Melphalan Response by Altering Fanconi Anemia (FA)/BRCA Pathway Expression and Function.

Danielle N. Yarde, BS, Lori A. Hazlehurst, Ph.D., Vasco A. Oliveira, Ph.D., Qing Chen, Ph.D., William S. Dalton, Ph.D, M.D.
Journal: Blood
Blood (2006) 108 (11): 840.
https://doi.org/10.1182/blood.V108.11.840.840
Published: 2006